Veranex vs Phillips-Medisize: full comparison for 2026
Quick verdict
Veranex (4.2/5) edges ahead of Phillips-Medisize (3.9/5) overall. Veranex is the better choice for device design plus clinical trials and reimbursement. Phillips-Medisize is the stronger option for drug delivery devices needing high-volume production. The right choice depends on your project size, budget, and required tech stack.
Veranex vs Phillips-Medisize: head-to-head summary
| Criterion | Veranex | Phillips-Medisize |
|---|---|---|
| Founded | 2021 | 1964 |
| HQ | Raleigh, NC, USA | Hudson, WI, USA |
| Team size | 800+ | ~7,000 |
| Rating | 4.2 / 5 | 3.9 / 5 |
| Primary differentiator | One contract can cover engineering, clinical studies, regulatory strategy and reimbursement | Design, molding and assembly of drug delivery devices under one global quality system |
| Pricing model | Fixed project, time and materials | Development contract plus manufacturing supply agreement |
| Min. engagement | Not disclosed | Not disclosed |
| Primary tech stack | ISO 13485 QMS, SolidWorks, Embedded C/C++ | Injection molding, Automated assembly, BLE |
| Industries served | Surgical & therapeutic devices, Diagnostics & lab devices, Drug delivery, Digital health | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices |
Veranex vs Phillips-Medisize: overview
Veranex
Veranex was formed in 2021 by Summit Partners, which combined Providence-based device developer Ximedica (founded 1985) with Quartesian and Boston Healthcare Associates. It has since acquired Experien Group, IMM Recherche, the healthcare design firm Worrell, Fusion Biotec and Horus Scientific. Headquartered in Raleigh, North Carolina, it reports more than 800 staff and offers product design and engineering, clinical research (CRO) services, regulatory work and market access consulting.
Phillips-Medisize
Phillips-Medisize is a subsidiary of Molex, itself owned by Koch Industries, and provides outsourced design, development and manufacturing to pharma, diagnostics and medical device companies. It is based in Wisconsin and has about 7,000 employees. Molex's purchase of inhalation specialist Vectura added combination-product expertise, and the combined team includes more than 1,200 engineers and scientists across 30 sites. A $110M manufacturing campus in Katowice, Poland, opened in November 2023.
Services and capabilities: Veranex vs Phillips-Medisize
| Capability | Veranex | Phillips-Medisize |
|---|---|---|
| Electronics & PCB design | ✓ | ✓ |
| Firmware & embedded software | ✗ | ✗ |
| SaMD & companion apps | ✗ | ✗ |
| Connected devices & IoT | ✗ | ✗ |
| Industrial design & human factors | ✓ | ✗ |
| Mechanical engineering | ✓ | ✓ |
| Device cybersecurity | ✗ | ✗ |
| Regulatory & QMS support | ✓ | ✓ |
| Manufacturing & scale-up | ✗ | ✓ |
Tech stack comparison: Veranex vs Phillips-Medisize
| Framework / platform | Veranex | Phillips-Medisize |
|---|---|---|
| Embedded C/C++ | ✓ | N/A |
| Embedded Linux | N/A | N/A |
| RTOS | N/A | N/A |
| BLE | N/A | ✓ |
| Cloud (AWS/Azure) | N/A | N/A |
| IEC 62304 | N/A | N/A |
| ISO 14971 | N/A | N/A |
| ISO 13485 QMS | ✓ | ✓ |
| Qt | N/A | N/A |
Pricing comparison: Veranex vs Phillips-Medisize
| Criterion | Veranex | Phillips-Medisize |
|---|---|---|
| Minimum engagement | Not disclosed | Not disclosed |
| Engagement models | Consulting, Fixed project, Time & materials | Fixed project, Manufacturing contract |
| Rate transparency | Not public | Not public |
| Price tier | Mid-market | Mid-market |
Target audience comparison: Veranex vs Phillips-Medisize
| Dimension | Veranex | Phillips-Medisize |
|---|---|---|
| Best company size | Startup to mid-market | Startup to mid-market |
| Best industries | Surgical & therapeutic devices, Diagnostics & lab devices, Drug delivery | Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices |
| Best use cases | Startup that needs design, a clinical study and an FDA strategy from one partner, Human-centered redesign of a surgical instrument | Autoinjector or pen injector development and production, Inhaler device for a pharma combination product |
| Typical project type | Consulting | Fixed project |
Veranex vs Phillips-Medisize: pros and cons
| Veranex | |
|---|---|
| + | Rare combination of engineering with CRO, regulatory and market access services |
| + | Ximedica brings decades of ISO 13485 device development experience |
| + | Worrell adds human-centered design for healthcare |
| + | Large enough to run several workstreams at once |
| - | Built from many acquisitions since 2021, so teams and processes are still being joined up |
| - | Private-equity ownership by Summit Partners |
| - | Buyers who only need engineering may pay for a broader structure than they use |
| Phillips-Medisize | |
|---|---|
| + | Very large manufacturing footprint across the US, Europe and Asia |
| + | Vectura deal added deep inhalation and combination-product skills |
| + | Development and manufacturing under one quality system |
| + | Experience with connected drug delivery |
| - | Owned by Molex and Koch Industries, so it suits large pharma more than small startups |
| - | Development work is usually tied to a manufacturing agreement |
| - | Less suited to software-heavy or early research projects |
Who should choose Veranex?
A typical fit: startup that needs design, a clinical study and an FDA strategy from one partner.
One contract can cover engineering, clinical studies, regulatory strategy and reimbursement. Minimum engagement is not publicly disclosed. Works best with clients in Surgical & therapeutic devices, Diagnostics & lab devices, Drug delivery, Digital health.
Who should choose Phillips-Medisize?
A typical fit: autoinjector or pen injector development and production.
Design, molding and assembly of drug delivery devices under one global quality system. Minimum engagement is not publicly disclosed. Works best with clients in Drug delivery, Diagnostics & lab devices, Surgical & therapeutic devices.
Decision matrix: Veranex vs Phillips-Medisize
| Your situation | Recommended choice |
|---|---|
| You need full-ownership delivery on a defined project scope | Veranex |
| You need a large dedicated team for an ongoing programme | Check each company's engagement model |
| Your budget is at the lower end | Compare: Veranex (Not disclosed) vs Phillips-Medisize (Not disclosed) |
| You need specialist depth in a specific vertical | Veranex |
| You need staff augmentation or team extension | Neither; consider alternatives that offer staff aug |
| You need consulting before committing to a build | Both may offer discovery engagements |
Use case fit: Veranex vs Phillips-Medisize
| Use case | Veranex fit | Phillips-Medisize fit | Winner |
|---|---|---|---|
| Startup that needs design, a clinical study and an FDA strategy from one partner | Strong | Limited | Veranex |
| Human-centered redesign of a surgical instrument | Strong | Limited | Veranex |
| Autoinjector or pen injector development and production | Limited | Strong | Phillips-Medisize |
| Inhaler device for a pharma combination product | Limited | Strong | Phillips-Medisize |
Verdict: Veranex vs Phillips-Medisize
Veranex (4.2/5) is the stronger overall choice for most Medical Device Development projects. One contract can cover engineering, clinical studies, regulatory strategy and reimbursement.
Phillips-Medisize (3.9/5) is worth a look if you need inhaler device for a pharma combination product. If your situation matches that, Phillips-Medisize is a competitive option.
Related comparisons
Veranex vs Phillips-Medisize FAQ
Is Veranex better than Phillips-Medisize?
Veranex (4.2/5) scores higher overall, but "better" depends on your use case. Veranex's strongest advantage: rare combination of engineering with CRO, regulatory and market access services. Phillips-Medisize's strongest advantage: very large manufacturing footprint across the US, Europe and Asia.
How do Veranex and Phillips-Medisize differ in pricing?
Veranex uses fixed project, time and materials pricing. Phillips-Medisize uses development contract plus manufacturing supply agreement pricing. Neither firm publishes a full rate card; a discovery call is required for project-specific quotes.
Which is better for enterprise: Veranex or Phillips-Medisize?
Phillips-Medisize is the larger team and typically the better enterprise-scale choice. For very large programmes, verify team size and compliance coverage directly with each company before shortlisting.
What are the main differences between Veranex and Phillips-Medisize?
Veranex's primary differentiator is: one contract can cover engineering, clinical studies, regulatory strategy and reimbursement. Phillips-Medisize's primary differentiator is: Design, molding and assembly of drug delivery devices under one global quality system. They also differ in team size (800+ vs ~7,000), minimum engagement (Not disclosed vs Not disclosed), and primary industries served (Surgical & therapeutic devices, Diagnostics & lab devices vs Drug delivery, Diagnostics & lab devices).
Verify all details directly with each company before making a decision.